Levetiracetam Neuraxpharm

Levetiracetam, the active ingredient in Levetiracetam Neuraxpharm, is an antiepileptic presented as an oral dosage form for oral use. It is employed to control partial, generalized tonic‑clonic and myoclonic seizures in patients requiring seizure management.

GNH USA supplies Levetiracetam Neuraxpharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug indicated for several seizure types.

Partial seizures: reduces the frequency of focal seizures in patients with epilepsy. Generalized tonic‑clonic seizures: helps control convulsive episodes in generalized epilepsy. Myoclonic seizures: diminishes rapid, involuntary muscle jerks associated with myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dizziness: sensation of light‑headedness or imbalance. - Headache: mild to moderate cranial pain. - Irritability: increased mood swings or agitation. - Nausea: upset stomach or feeling of queasiness. - Nasal congestion: blocked or runny nose.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood changes: depression, suicidal thoughts, or severe anxiety. - Blood disorders: low white blood cell or platelet counts. - Hepatic dysfunction: signs of liver injury such as jaundice. - Skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Multiorgan failure: extremely rare but life‑threatening systemic involvement.

Before initiating therapy, consider the following safety measures.

Renal function: assess kidney performance and adjust dose if necessary. Pregnancy status: evaluate risks and benefits, as safety data are limited. Concomitant CNS depressants: monitor for enhanced sedation. Psychiatric history: watch for worsening mood or behavioral changes. Alcohol consumption: advise moderation to avoid additive CNS effects. Store at ambient temperature: keep below 25 °C, retain original packaging, protect from moisture and direct sunlight.

Levetiracetam can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: can lower levetiracetam concentrations. - Phenytoin: may decrease levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Alcohol: additive CNS depression, monitor sedation. - Opioids: increased risk of respiratory depression. - Other antiepileptics: potential additive side‑effects, adjust monitoring.